<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1186/cc13956</dc:identifier><dc:language>eng</dc:language><dc:creator>Lorente, L.</dc:creator><dc:creator>Martín, M. M.</dc:creator><dc:creator>López-Gallardo, E.</dc:creator><dc:creator>Iceta, R.</dc:creator><dc:creator>Blanquer, J.</dc:creator><dc:creator>Solé-Violán, J.</dc:creator><dc:creator>Labarta, L.</dc:creator><dc:creator>Díaz, C.</dc:creator><dc:creator>Jiménez, A.</dc:creator><dc:creator>Montoya, J.</dc:creator><dc:creator>Ruiz-Pesini, E.</dc:creator><dc:title>Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients</dc:title><dc:identifier>ART-2014-98813</dc:identifier><dc:description>Introduction: In a previous study with 96 septic patients, we found that circulating platelets in 6-months surviving septic patients showed higher activity and quantity of cytochrome c oxidase (COX) normalized by citrate synthase (CS) activity at moment of severe sepsis diagnosis than non-surviving septic patients. The objective of this study was to estimate whether COX specific activity during the first week predicts 1-month sepsis survival in a larger cohort of patients.Methods: Using a prospective, multicenter, observational study carried out in six Spanish intensive care units with 198 severe septic patients, we determined COX activity per proteins (COXact/Prot) in circulating platelets at day 1, 4 and 8 of the severe sepsis diagnosis. Endpoints were 1-month and 6-months mortality.Results: Survivor patients (n = 130) showed higher COXact/Prot (P 0.30 mOD/min/mg at day 1 (P = 0.002), 4 (P = 0.006) and 8 (P = 0.02) was associated independently with 1-month mortality. Area under the curve of COXact/Prot at day 1, 4 and 8 to predict 30-day survival were 0.70 (95% CI = 0.63-0.76; P &lt; 0.001), 0.71 (95% CI = 0.64-0.77; P &lt; 0.001) and 0.71 (95% CI = 0.64-0.78; P &lt; 0.001), respectively.Conclusions: The new findings of our study, to our knowledge the largest series reporting data about mitochondrial function during follow-up in septic patients, were that septic patients that survive 1-month have a higher platelet cytochrome oxidase activity at moment of sepsis diagnosis and during the first week than non-survivors, and that platelet cytochrome oxidase activity at moment of sepsis diagnosis and during the first week could be used as biomarker to predict the clinical outcome in septic patients.</dc:description><dc:date>2014</dc:date><dc:source>http://zaguan.unizar.es/record/130406</dc:source><dc:doi>10.1186/cc13956</dc:doi><dc:identifier>http://zaguan.unizar.es/record/130406</dc:identifier><dc:identifier>oai:zaguan.unizar.es:130406</dc:identifier><dc:identifier.citation>Critical care 18, 3 (2014), R136 [17 pp]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>